SYVAXA Trademark

Trademark Overview


On Friday, February 22, 2002, a trademark application was filed for SYVAXA with the United States Patent and Trademark Office. The USPTO has given the SYVAXA trademark a serial number of 78110453. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, November 7, 2003. This trademark is owned by Genzyme Corporation. The SYVAXA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use

General Information


Serial Number78110453
Word MarkSYVAXA
Filing DateFriday, February 22, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, November 7, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 6, 2002

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 28, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701

Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701

Trademark Events


Event DateEvent Description
Monday, January 5, 2004ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 6, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2002EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 6, 2002PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2002NOTICE OF PUBLICATION
Friday, June 7, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 7, 2002ASSIGNED TO EXAMINER

Related Keywords


syvaxa human vaccines